The median year since 1928 has experienced a 13% intra-year drawdown in the S&P 500, making 2023 relatively mild by comparison
The 7.8% pullback in February-March is the largest thus far. Soruce: Charlie Bilello
Eli Lilly stock hit a new record high yesterday as the company continues to record a surge in sales for its buzzy diabetes drug Mounjaro
Sales of Mounjaro, which has also gained popularity for weight loss, came in at $979.7 million for the second quarter, up from $16 million a year earlier when it was introduced (2Q results were publichsed 2 weeks ago). That helped the drug company post higher-than-expected sales for the second quarter. Novo Nordisk is also surfing on the strong demand for a similar weight loss blockbuster
The best performance stocks in the S&P 500 this year...
Source: Charlie Bilello
Crude Oil cannot be stopped! It just had its 7th consecutive green week, its longest winning streak since February 2022
Source: Barchart
EM returns over past 5-10yrs have been lackluster, w/most EM equities returning low-to-mid single digits
Over longer-term, returns range from extraordinary (India: 1000%) to respectable (Indonesia: 469%) despite volatility & some prolonged periods of choppy trading, BofA has calculated. All EMs have outperformed China's 22% total return. Source: HolgerZ, BofA, Bloomberg
Should you do the opposite of what Wall Street strategists say? Data over the last 3.5 years suggests that strategists underperform the S&P 500
Source: Barchart, Bloomberg
MSCI World long-term performance by style
Quality outperforms by far with a lower standard deviation (NB: past returns are not a guarantee for future returns). Source: Invest In Assets | Stock Market Investing
The top 3 country ETFs in 2023:
1) Nigeria $NGE: +48.3% 2) Greece: $GREK: +47.5% 3) Argentina $ARGT: +38.7% Source: Charlie Bilello
